Oscar Health, Inc. (NYSE:OSCR - Get Free Report) Vice Chairman Joshua Kushner acquired 276,040 shares of the firm's stock in a transaction that occurred on Monday, November 11th. The shares were bought at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the purchase, the insider now owns 5,031,262 shares of the company's stock, valued at $68,324,537.96. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.
Joshua Kushner also recently made the following trade(s):
- On Wednesday, November 13th, Joshua Kushner acquired 358,619 shares of Oscar Health stock. The stock was purchased at an average price of $13.74 per share, with a total value of $4,927,425.06.
Oscar Health Stock Performance
Shares of OSCR stock opened at $13.48 on Thursday. The company has a fifty day moving average price of $18.28 and a two-hundred day moving average price of $18.30. Oscar Health, Inc. has a one year low of $6.93 and a one year high of $23.79. The stock has a market cap of $3.26 billion, a P/E ratio of -224.63, a P/E/G ratio of 12.49 and a beta of 1.67. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.91.
First JFK… next Elon?
From Porter & Company | Ad
Today, I have another controversial prediction.
One which I will take no pleasure in seeing come true.
See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
I share with you in this special investigative documentary.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company's revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter last year, the business posted ($0.29) earnings per share. As a group, equities analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.
Wall Street Analyst Weigh In
OSCR has been the topic of several recent analyst reports. UBS Group began coverage on Oscar Health in a report on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective on the stock. Piper Sandler restated an "overweight" rating and issued a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. Finally, Bank of America lowered Oscar Health from a "neutral" rating to an "underperform" rating and dropped their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $22.93.
Read Our Latest Analysis on Oscar Health
Institutional Investors Weigh In On Oscar Health
Several hedge funds have recently added to or reduced their stakes in OSCR. Point72 Hong Kong Ltd bought a new position in shares of Oscar Health in the second quarter valued at about $78,000. Quest Partners LLC acquired a new stake in Oscar Health during the second quarter worth approximately $93,000. KBC Group NV boosted its holdings in shares of Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company's stock worth $97,000 after acquiring an additional 1,328 shares during the period. Amalgamated Bank boosted its holdings in shares of Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company's stock worth $106,000 after acquiring an additional 1,458 shares during the period. Finally, Optimum Investment Advisors acquired a new position in shares of Oscar Health in the third quarter valued at approximately $142,000. Institutional investors and hedge funds own 75.70% of the company's stock.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
